Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded encouraging developments into new therapeutic approaches. Current focus centers on modifying the underlying causes of MSA. One avenue under investigation involves therapeutic interventions to modulate the dysregulation of specific